Deploying vibration-controlled transient elastography/controlled attenuation parameter devices at the population level is a financially advantageous solution to address the epidemic of fatty liver disease.
Elaine Zhao, BS
Advertisement
Articles by Elaine Zhao, BS
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
Hans Lee, MD, Discusses “Off-the-Shelf” Solution for Rare Blood Disorder With No Approved Therapies
2
FDA Approves Another OTC Naloxone Nasal Spray for Opioid Overdose
3
United Therapeutics Plans FDA Submission for Inhaled Treprostinil in IPF
4
HDV Combo Shows No Relapses at 2 Years: Tarik Asselah, MD, PhD
5